核磁共振与B超诊断妇科盆腔肿瘤的临床价值探究

摘要

Objective To study the clinical values of MRI and B-ultrasonography in the diagnoses of gynecological pelvic tumors.Methods From September 2014 to September 2016,130 patients with gynecological pelvic tumors were randomly selected and examined by MRI and B-ultrasonography respectively.MRI and B-uhrasonography were compared on the misdiagnosis and missed diagnosis rate,detection rate of malignant tumor as well as diagnosis coincidence rate.Results The detection rate of malignant tumor,the misdiagnosis and missed diagnosis rate and the diagnosis coincidence rate of MRI were 96.15％,10.77％ and 89.23％ respectively,those of B-ultrasonography were 76.92％,24.62％ and 75.38％ respectively,and there were significant differences between all the rates of MRI and B-ultrasonography (P＜0.05).Conclusion MRI diagnoses pelvic tumors effectively,while behaves not so well as B-ultrasonography in cost,timeliness and scan time.%目的:研究核磁共振与B超在诊断妇科盆腔肿瘤中的临床价值.方法:随机抽取医院2014年9月至2016年9月妇科130例盆腔肿瘤患者作为研究对象,分别进行核磁共振与B超检查,分析并比较2种检查方法的漏诊误诊率、恶性肿瘤分辨率及诊断符合率.结果:核磁共振检查的恶性肿瘤分辨率为96.15％,B超检查为76.92％,前者明显高于后者(x2=20.63,P＜0.05);核磁共振检查的漏诊误诊率(10.77％)低于B超检查(24.62％);核磁共振检查的诊断符合率(89.23％)明显高于B超检查(75.38％).以上3组数据均存在显著差异(P＜0.05),并具有统计学意义.结论:核磁共振检查能够有效地诊断盆腔肿瘤,并具有较高的临床价值,但相比于B超检查,价格较高、实时性较差、扫描时间较长.